Page last updated: 2024-11-02

pentoxifylline and Anemia, Hemolytic

pentoxifylline has been researched along with Anemia, Hemolytic in 3 studies

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research Excerpts

ExcerptRelevanceReference
"So pentoxifylline was added to the regimen."1.31Successful combination therapy--flunarizine, pentoxifylline, and cholestyramine--for spur cell anemia. ( Abe, M; Aihara, K; Akaike, M; Azuma, H; Ikeda, Y; Matsumoto, T; Sugihara, T, 2001)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
James, SH1
Meyers, AM1
Aihara, K1
Azuma, H1
Ikeda, Y1
Akaike, M1
Abe, M1
Sugihara, T1
Matsumoto, T1
Jim, RT1

Other Studies

3 other studies available for pentoxifylline and Anemia, Hemolytic

ArticleYear
Microangiopathic hemolytic anemia as a complication of diabetes mellitus.
    The American journal of the medical sciences, 1998, Volume: 315, Issue:3

    Topics: Anemia, Hemolytic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Erythro

1998
Successful combination therapy--flunarizine, pentoxifylline, and cholestyramine--for spur cell anemia.
    International journal of hematology, 2001, Volume: 73, Issue:3

    Topics: Adult; Anemia, Hemolytic; Anticholesteremic Agents; Calcium; Calcium Channel Blockers; Chelating Age

2001
New therapy for microangiopathic hemolytic anemia caused by cardiac valve prosthesis: a case report [correction of new therapy for cardiac valve prosthesis caused by microangiopathic hemolytic anemia: a case report].
    Hawaii medical journal, 1988, Volume: 47, Issue:6

    Topics: Aged; Anemia, Hemolytic; Bioprosthesis; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Pentoxif

1988